Sep 2026· Interdisciplinary cardiovascular and thoracic surgery· 0 citations
Medicine
TL;DR
Long-term readmission after CABG is driven primarily by clinical risk rather than biological sex, underscoring the need for targeted management of high-risk comorbidities.
Abstract
Objectives
Readmissions after coronary artery bypass grafting (CABG) are common and contribute substantially to long-term morbidity, yet extended follow-up data remain limited. Women experience higher perioperative morbidity, mortality, and short-term readmission rates than men, but long-term sex-specific patterns of readmission after CABG are poorly defined.
Methods
Nationwide data for patients undergoing CABG between 2015 and 2021 from the Austrian Cardiac Surgery Registry were linked to the federal social insurance claims database to assess long-term cardiovascular (CV) and all-cause readmission. Cumulative incidence functions accounting for the competing risk of death and cause-specific Cox proportional hazards models were used.
Results
A total of 12,169 patients (2,192 [18%] women) were included. Cumulative incidences of CV readmission were higher in women than in men at 1 year (19.1% vs. 17.3%), 4 years (37.8% vs. 34.9%), and 6 years (46.9% vs 43.4%) (p = 0.003). All-cause readmission showed a similar pattern at 1 year (42.2% vs. 37.6%), 4 years (69.6% vs. 66.7%), and 6 years (79.1% vs 75.9%) (p = 0.0004). Female sex was not independently associated with CV (HR 1.01, 95% CI 0.94-1.10, p = 0.73) or all-cause readmission (HR 0.99, 95% CI 0.94-1.05, p = 0.74). Earlier readmission correlated with earlier CV (ρ = 0.36, 95% CI 0.28-0.44) and all-cause death (ρ = 0.39, 95% CI 0.34-0.43).
Conclusions
Women experienced higher unadjusted cumulative incidences of readmission. Long-term readmission after CABG is driven primarily by clinical risk rather than biological sex, underscoring the need for targeted management of high-risk comorbidities.
INTRODUCTION
Most studies comparing Off-pump and On-pump coronary artery bypass grafting (CABG) have primarily focused on short-term outcomes. The aim of this study was therefore to evaluate and compare long-term complications and survival between these surgical approaches.
MATERIAL AND METHODS
This retrospective stu...
Kristjana Lind Olafsdottir, Luis Gisli Rabelo, Boðvar Pall Asgeirsson et al.· Icelandic Medical Journal· 0 citations
Background: The comparative effectiveness of off-pump (OPCAB) and on-pump coronary artery bypass grafting (ONCAB) in severe left ventricular dysfunction remains uncertain. Methods: We conducted a retrospective institutional cohort study of isolated CABG procedures performed from 1996 to 2023. Registry-coded severe dysf...
Man-Yiu Lau, Maria Comanici, N. Marczin et al.· British Journal of Healthcar...· 0 citations
Background/Objectives: Postoperative atrial fibrillation (POAF) is a common complication of coronary artery bypass grafting (CABG) and may recur during cardiac rehabilitation (CR); its long-term prognostic value remains unclear. We evaluated the impact of POAF on a composite endpoint of all-cause mortality and non-fata...
Roberto F. E. Pedretti, Lucio Addeo, Pasquale Campana et al.· Journal of Clinical Medicine· 0 citations
OBJECTIVE
The clinical significance of prior percutaneous coronary intervention (PCI) in patients undergoing coronary artery bypass grafting (CABG) remains debated, particularly regarding long-term mortality, need for repeat revascularization, and the prognostic value of intraoperative graft flow.
METHODS
In this sin...
J. Kletzer, M. Kreibich, Laurin Micek et al.· Interdisciplinary cardiovasc...· 0 citations
Background This study aimed to compare the perioperative and early-to-mid-term outcomes of hybrid coronary revascularization (HCR) and minimally invasive multivessel coronary artery bypass grafting (MICS-CABG) for treating multivessel coronary artery disease (MVCAD). Methods We conducted a retrospective observational c...
Ting Ren, Hao-Yi Yao, Zhao-Hui Cheng et al.· Frontiers in Cardiovascular...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.